Bridgefront Capital’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.53M Buy
+60,327
New +$5.28M 1.46% 1
2025
Q1
– Sell
-10,137
Closed -$922K – 654
2024
Q4
$922K Buy
10,137
+4,790
+90% +$457K 0.31% 76
2024
Q3
$555K Buy
+5,347
New +$545K 0.21% 158
2023
Q3
– Sell
-9,132
Closed -$704K – 421
2023
Q2
$704K Buy
+9,132
New +$707K 0.38% 58
2022
Q4
– Sell
-5,940
Closed -$417K – 381
2022
Q3
$417K Buy
+5,940
New +$466K 0.43% 65
2021
Q3
– Sell
-13,931
Closed -$1.13M – 384
2021
Q2
$1.13M Sell
13,931
-3,287
-19% -$269K 0.43% 32
2021
Q1
$1.36M Buy
+17,218
New +$1.35M 0.42% 24

Other funds holding CL

Bridgefront Capital's CL Position: Q2 2026 in Review

Bridgefront Capital opened a new position in Colgate-Palmolive (CL) in Q2 2026: 60,327 shares worth $5.53M. The stake represents 1.46% of the portfolio and ranks #1 among its holdings. This is a return to the name: Bridgefront Capital previously reported a position in CL as recently as Q4 2024.

Bridgefront Capital first reported a position in CL in Q1 2021 and has held it in 7 quarters since. 2,028 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Bridgefront Capital held 60,327 shares of Colgate-Palmolive worth $5.53M as of Q2 2026.
  • Colgate-Palmolive was a new Bridgefront Capital position in Q2 2026.
  • Colgate-Palmolive made up 1.46% of Bridgefront Capital's portfolio in Q2 2026, its #1 holding.
  • Bridgefront Capital first reported a position in Colgate-Palmolive in Q1 2021 and has held it in 7 quarters since.
  • 2,028 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Bridgefront Capital's 13F filing for Q2 2026, filed 14 Aug 2026.